Clinical Trial Update: QLC7401 in Participants With Heterozygous Familial Hypercholesterolemia (HeFH) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for QLC7401 in adults with heterozygous familial hypercholesterolemia; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heterozygous Familial Hypercholesterolemia

Drugs mentioned

• QLC7401

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Heterozygous Familial Hypercholesterolemia (HeFH) | Phase 3 | Status: NOT_YET_RECRUITING